Truist Financial Corp Grows Position in Agilent Technologies, Inc. $A

Truist Financial Corp lifted its stake in Agilent Technologies, Inc. (NYSE:A) by 28.1% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 37,822 shares of the medical research company’s stock after buying an additional 8,299 shares during the quarter. Truist Financial Corp’s holdings in Agilent Technologies were worth $5,146,000 at the end of the most recent reporting period.

Other hedge funds have also recently modified their holdings of the company. Massachusetts Financial Services Co. MA increased its position in Agilent Technologies by 13.8% in the fourth quarter. Massachusetts Financial Services Co. MA now owns 14,147,601 shares of the medical research company’s stock worth $1,925,064,000 after purchasing an additional 1,713,216 shares during the last quarter. Wellington Management Group LLP increased its position in Agilent Technologies by 4.8% during the third quarter. Wellington Management Group LLP now owns 9,380,521 shares of the medical research company’s stock valued at $1,203,990,000 after acquiring an additional 433,342 shares during the last quarter. Generation Investment Management LLP increased its position in Agilent Technologies by 10.1% during the third quarter. Generation Investment Management LLP now owns 6,357,953 shares of the medical research company’s stock valued at $816,043,000 after acquiring an additional 582,093 shares during the last quarter. Ameriprise Financial Inc. increased its position in Agilent Technologies by 15.1% during the third quarter. Ameriprise Financial Inc. now owns 2,708,591 shares of the medical research company’s stock valued at $347,685,000 after acquiring an additional 354,480 shares during the last quarter. Finally, Troy Asset Management Ltd increased its position in Agilent Technologies by 0.3% during the third quarter. Troy Asset Management Ltd now owns 2,404,161 shares of the medical research company’s stock valued at $308,574,000 after acquiring an additional 6,341 shares during the last quarter.

Agilent Technologies Trading Down 0.1%

A stock opened at $115.52 on Monday. The company has a market capitalization of $32.65 billion, a PE ratio of 25.50, a P/E/G ratio of 2.43 and a beta of 1.22. Agilent Technologies, Inc. has a 12 month low of $106.79 and a 12 month high of $160.27. The firm’s 50-day moving average is $115.99 and its 200 day moving average is $131.97. The company has a debt-to-equity ratio of 0.44, a current ratio of 2.07 and a quick ratio of 1.59.

Agilent Technologies (NYSE:A) last posted its quarterly earnings results on Wednesday, February 25th. The medical research company reported $1.36 EPS for the quarter, missing the consensus estimate of $1.37 by ($0.01). The company had revenue of $1.80 billion during the quarter, compared to analysts’ expectations of $1.81 billion. Agilent Technologies had a return on equity of 24.49% and a net margin of 18.26%.The company’s quarterly revenue was up 7.0% on a year-over-year basis. During the same period in the prior year, the business earned $1.31 EPS. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. On average, research analysts anticipate that Agilent Technologies, Inc. will post 5.95 EPS for the current year.

Agilent Technologies Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, April 22nd. Investors of record on Tuesday, March 31st were paid a $0.255 dividend. This represents a $1.02 annualized dividend and a yield of 0.9%. The ex-dividend date of this dividend was Tuesday, March 31st. Agilent Technologies’s dividend payout ratio (DPR) is currently 22.52%.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on A shares. Morgan Stanley cut their price objective on shares of Agilent Technologies from $180.00 to $160.00 and set an “overweight” rating on the stock in a research report on Tuesday, March 3rd. Wells Fargo & Company cut their price objective on shares of Agilent Technologies from $175.00 to $165.00 and set an “overweight” rating on the stock in a research report on Thursday, February 26th. TD Cowen cut their price objective on shares of Agilent Technologies from $170.00 to $157.00 and set a “buy” rating on the stock in a research report on Thursday, February 26th. Wall Street Zen cut shares of Agilent Technologies from a “buy” rating to a “hold” rating in a research report on Saturday. Finally, UBS Group cut their price objective on shares of Agilent Technologies from $180.00 to $165.00 and set a “buy” rating on the stock in a research report on Thursday, February 26th. Two equities research analysts have rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat.com, Agilent Technologies currently has a consensus rating of “Buy” and a consensus target price of $163.71.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.